nivolumab,bempegaldesleukin
bms,nektar
['$bmy', 'bristol']
$bmy $nktr #esmo22: here are the disastrous data that crushed hopes for a $3.6b bristol myers combo deal - 
News and analysis of biomedical, biopharma, biotech, biosciences, pharmaceutical, and technology equities